Search

everythinglearnresearchcommunity

for

Search:↓

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

Increased DHT formation in skin can cause hair loss, acne, and excessive hair growth, and antiandrogens might treat these conditions.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Testosterone's muscle-building effects do not require its conversion to DHT.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Mice with human gene experienced hair loss when treated with DHT.

Finasteride lowers scalp and blood DHT levels, potentially treating male-pattern baldness.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Dihydrotestosterone specifically binds to hamster sebaceous glands, with a higher affinity than testosterone.

Dutasteride reduces DHT more effectively than finasteride.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

The paper suggests that hair loss might be caused by skull growth, not just DHT's effect on hair follicles, and calls for more research.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.